Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolus (EOLS) EBT (2018 - 2025)

Evolus' EBT history spans 8 years, with the latest figure at $515000.0 for Q4 2025.

  • For Q4 2025, EBT rose 108.11% year-over-year to $515000.0; the TTM value through Dec 2025 reached -$51.0 million, down 2.43%, while the annual FY2025 figure was -$51.0 million, 2.43% down from the prior year.
  • EBT reached $515000.0 in Q4 2025 per EOLS's latest filing, up from -$15.6 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $6.4 million in Q1 2021 to a low of -$23.4 million in Q2 2022.
  • Average EBT over 5 years is -$14.2 million, with a median of -$16.2 million recorded in 2021.
  • Peak YoY movement for EBT: surged 132.92% in 2021, then tumbled 372.93% in 2022.
  • A 5-year view of EBT shows it stood at -$18.2 million in 2021, then grew by 27.86% to -$13.1 million in 2022, then rose by 10.54% to -$11.7 million in 2023, then surged by 45.83% to -$6.4 million in 2024, then skyrocketed by 108.11% to $515000.0 in 2025.
  • Per Business Quant, the three most recent readings for EOLS's EBT are $515000.0 (Q4 2025), -$15.6 million (Q3 2025), and -$17.1 million (Q2 2025).